Assessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
Cyrille C. Chéry
Advertisement
Cyrille C. Chéry is a senior scientist, analytical sciences for biologicals, UCB Pharma SA
Articles by Cyrille C. Chéry
Advertisement
Latest Updated Articles
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and OpportunitiesPublished: March 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
Challenges for the Global Manufacturing of Vaccines
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
